Mankind Pharma launches Dapagliflozin brand Justoza for diabetes, heart failure, CKD
New Delhi: Mankind Pharma has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat Diabetes, Heart Failure and Chronic Kidney Disease.
The Active Pharmaceutical Ingredient is procured from DMF facility approved by USFDA, EU GMP and WHO GMP, which ensures highest global efficacy and safety standards. It is believed that quality of DMF grade facility product is of highest standard in terms of safety and efficacy.
DMF (Drug Master File) is an important confidential document submitted to USFDA by a manufacturer in order to get approval for exporting pharmaceutical drugs and its ingredients to US market. Drug Master File (DMF) provides necessary documentation to regulatory agencies to prove that the manufacturing facility satisfies the quality and safety requirements of USFDA and other regulatory bodies across world. FDA ensures that the drug substance which is subject of the DMF is of the best quality.
Speaking on the launch, Atish Majumdar, President, Mankind Pharma, said, "The core at Mankind Pharma is to make quality and affordable medicines accessible to the Indian citizens. Launching API DMF Grade Dapagliflozin is an innovative futuristic approach to provide the best in class quality to the patients. This is just the beginning, we are committed to add more medicines to the list. Serving life is a mission in progress for us at Mankind Pharma."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.